{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:45:06Z","timestamp":1791812706743,"version":"4.3.4"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Master in Nutrition and Dietetics in Nephrology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Remnant cholesterol (remnant-C) has emerged as a marker of residual cardiovascular risk beyond low-density lipoprotein cholesterol (LDL-C) but data in haemodialysis populations remain limited. We investigated the association of remnant-C with cardiovascular and mortality outcomes in maintenance haemodialysis patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This post-hoc analysis included 624 patients from the prospective RISCAVID cohort. Remnant-C was calculated as total cholesterol minus high-density lipoprotein cholesterol minus directly measured LDL-C. The primary endpoint was 3-point major adverse cardiovascular events (MACE), defined as cardiovascular death, nonfatal myocardial infarction, or nonfatal ischaemic stroke. All-cause mortality was analysed as a secondary endpoint. Associations were assessed using multivariable Cox regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a median follow-up of 31 months, 328 patients experienced a 3-point MACE and 375 died. Remnant-C was independently associated with 3-point MACE after adjustment for age, sex, traditional cardiovascular risk factors, LDL-C, and statin therapy (HR 1.06 per 10 mg\/dl increase, 95% CI 1.01\u20131.11). The association remained significant after additional adjustment for the Geriatric Nutritional Risk Index (GNRI) and normalized protein catabolic rate. Restricted cubic spline analysis showed a progressive increase in cardiovascular risk across increasing remnant-C concentrations without evidence of a nonlinear threshold effect. For all-cause mortality, neither remnant-C nor LDL-C retained prognostic significance after multivariable adjustment. Conversely, GNRI was independently associated with mortality risk, whereas it was not associated with cardiovascular events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In maintenance haemodialysis patients, remnant-C was independently associated with major cardiovascular events but not with all-cause mortality, whereas the GNRI was associated with mortality but not cardiovascular outcomes. These findings suggest distinct contributions of residual atherogenic risk and nutritional status to cardiovascular and survival outcomes in end-stage kidney disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfag337","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:13:09Z","timestamp":1790334789000},"source":"Crossref","is-referenced-by-count":0,"title":["Remnant cholesterol and cardiovascular risk in maintenance haemodialysis"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1223-0167","authenticated-orcid":false,"given":"Diego","family":"Moriconi","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ulivelli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8995-936X","authenticated-orcid":false,"given":"Adamasco","family":"Cupisti","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Giannese","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, AOUP , Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Cantaluppi","sequence":"additional","affiliation":[{"name":"Nephrology and Kidney Transplantation Unit, Department of Translational Medicine, University of Piemonte Orientale (UPO), \u201cMaggiore Della Carit\u00e0\u201d University Hospital , Novara ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Migliori","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, Versilia Hospital ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Panichi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the RISCAVID group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Manca","family":"Rizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Mangione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Casani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bozzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Grazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Batini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"2026101208471592500_bib1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/sdi.12694","article-title":"Hemodialysis-induced cardiovascular disease","volume":"31","author":"Ahmadmehrabi","year":"2018","journal-title":"Semin Dial"},{"key":"2026101208471592500_bib2","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3390\/life11070666","article-title":"Relationship between vascular calcification, protein-energy wasting syndrome, and sarcopenia in maintenance automated peritoneal dialysis","volume":"11","author":"Leal-Alegre","year":"2021","journal-title":"Life"},{"key":"2026101208471592500_bib3","doi-asserted-by":"publisher","first-page":"800950","DOI":"10.3389\/fphar.2022.800950","article-title":"Inflammation and cardiovascular disease associated with hemodialysis for end-stage renal disease","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026101208471592500_bib4","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S2213-8587(16)30156-5","article-title":"Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials","volume":"4","author":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026101208471592500_bib5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.ahj.2010.08.012","article-title":"Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease","volume":"160","author":"Sharp Collaborative Group null","year":"2010","journal-title":"Am Heart J"},{"key":"2026101208471592500_bib6","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N Engl J Med"},{"key":"2026101208471592500_bib7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/life11040315","article-title":"Lipoprotein abnormalities in chronic kidney disease and renal transplantation","volume":"11","author":"Barbagallo","year":"2021","journal-title":"Life"},{"key":"2026101208471592500_bib8","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/eurheartj\/ehac783","article-title":"What is \u201cremnant cholesterol\u201d?","volume":"44","author":"St\u00fcrzebecher","year":"2023","journal-title":"Eur Heart J"},{"key":"2026101208471592500_bib9","doi-asserted-by":"publisher","first-page":"e44202","DOI":"10.7759\/cureus.44202","article-title":"Remnant cholesterol, a valuable biomarker for assessing arteriosclerosis and cardiovascular risk: a systematic review","volume":"15","author":"Chen","year":"2023","journal-title":"Cureus"},{"key":"2026101208471592500_bib10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/1753-0407.13362","article-title":"Remnant cholesterol is independently associated with diabetes, even if the traditional lipid is at the appropriate level: a report from the REACTION study","volume":"15","author":"Li","year":"2023","journal-title":"J Diabetes"},{"key":"2026101208471592500_bib11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2025.13693","article-title":"Small dense LDL: an underestimated driver of atherosclerosis (review)","volume":"32","author":"Bekbossynova","year":"2025","journal-title":"Mol Med Rep"},{"key":"2026101208471592500_bib12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.34172\/jcvtr.33145","article-title":"Association between small dense low-density lipoprotein and carotid intima-media thickness","volume":"16","author":"Khosravi","year":"2024","journal-title":"J Cardiovasc Thorac Res"},{"key":"2026101208471592500_bib13","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.5551\/jat.63397","article-title":"Elevated remnant cholesterol is associated with adverse cardiovascular outcomes in patients with acute coronary syndrome","volume":"29","author":"Shao","year":"2022","journal-title":"J Atheroscler Thrombosis"},{"key":"2026101208471592500_bib14","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1161\/ATVBAHA.124.321387","article-title":"Impaired renal function with higher remnant cholesterol related to risk of atherosclerotic cardiovascular disease: a cohort study","volume":"44","author":"El\u00edas-L\u00f3pez","year":"2024","journal-title":"Arterioscler Throm Vasc Biol"},{"key":"2026101208471592500_bib15","doi-asserted-by":"publisher","DOI":"10.23876\/j.krcp.25.447","article-title":"Associations between remnant cholesterol and cardiovascular events in patients undergoing dialysis: a nationwide cohort study","author":"Kim","year":"2026","journal-title":"Kidney Res Clin Pract"},{"key":"2026101208471592500_bib16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/hdi.13199","article-title":"Correlation of the Geriatric Nutritional Risk Index (GNRI) with other indicators of nutrition in chronic hemodialysis patients","volume":"29","author":"Kosmadakis","year":"2025","journal-title":"Hemodial Int"},{"key":"2026101208471592500_bib17","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.1097\/MS9.0000000000002378","article-title":"Geriatric nutritional risk index and quality of life among elderly hemodialysis patients: a cross-sectional study","volume":"86","author":"Nouri","year":"2024","journal-title":"Ann Med Surg"},{"key":"2026101208471592500_bib18","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1093\/ndt\/gfm951","article-title":"Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study","volume":"23","author":"Panichi","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"2026101208471592500_bib19","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1681\/ASN.V75780","article-title":"Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics","volume":"7","author":"Depner","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"2026101208471592500_bib20","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"2026101208471592500_bib21","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1007\/s00125-023-06016-0","article-title":"Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study","volume":"66","author":"Wadstr\u00f6m","year":"2023","journal-title":"Diabetologia"},{"key":"2026101208471592500_bib22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026101208471592500_bib23","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1016\/j.jacc.2020.10.008","article-title":"Remnant cholesterol, Not LDL cholesterol, is associated with incident cardiovascular disease","volume":"76","author":"Casta\u00f1er","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026101208471592500_bib24","doi-asserted-by":"publisher","first-page":"120605","DOI":"10.1016\/j.atherosclerosis.2025.120605","article-title":"Remnant cholesterol and particle number of VLDL subfractions in coronary artery disease: pros and cons","volume":"412","author":"Johansen","year":"2026","journal-title":"Atherosclerosis"},{"key":"2026101208471592500_bib25","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1177\/2047487319887578","article-title":"Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease","volume":"27","author":"Elshazly","year":"2020","journal-title":"Eur J Prev Cardiolog"},{"key":"2026101208471592500_bib26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5527\/wjn.v4.i1.83","article-title":"Lipid abnormalities in kidney disease and management strategies","volume":"4","author":"Pandya","year":"2015","journal-title":"World J Nephrol"},{"key":"2026101208471592500_bib27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","article-title":"Inflammation and atherosclerosis: signaling pathways and therapeutic intervention","volume":"7","author":"Kong","year":"2022","journal-title":"Sig Transduct Target Ther"},{"key":"2026101208471592500_bib28","doi-asserted-by":"publisher","first-page":"S498","DOI":"10.1086\/432005","article-title":"Triglyceride-rich lipoproteins as agents of innate immunity","volume":"41","author":"Barcia","year":"2005","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"2026101208471592500_bib29","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/ATVBAHA.116.308834","article-title":"Remnant cholesterol elicits arterial wall inflammation and a multilevel cellular immune response in humans","volume":"37","author":"Bernelot\u00a0Moens","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026101208471592500_bib30","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.113.003008","article-title":"Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation","volume":"128","author":"Varbo","year":"2013","journal-title":"Circulation"},{"key":"2026101208471592500_bib31","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/antiox9111079","article-title":"Oxidative stress in ESRD patients on dialysis and the risk of cardiovascular diseases","volume":"9","author":"Rysz","year":"2020","journal-title":"Antioxidants"},{"key":"2026101208471592500_bib32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3390\/toxins12060361","article-title":"Endothelial damage, inflammation and immunity in chronic kidney disease","volume":"12","author":"Diaz-Ricart","year":"2020","journal-title":"Toxins"},{"key":"2026101208471592500_bib33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1053\/j.jrn.2004.01.005","article-title":"Outcome research, nutrition, and reverse epidemiology in maintenance dialysis patients","volume":"14","author":"Kalantar-Zadeh","year":"2004","journal-title":"J Ren Nutr"},{"key":"2026101208471592500_bib34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000080241","article-title":"Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics","volume":"27","author":"Wanner","year":"2004","journal-title":"Kidney Blood Press Res"},{"key":"2026101208471592500_bib35","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3390\/ijerph8051631","article-title":"Protein-energy wasting and mortality in chronic kidney disease","volume":"8","author":"Bonanni","year":"2011","journal-title":"Int J Environ Res Public Health"},{"key":"2026101208471592500_bib36","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.clnu.2016.06.007","article-title":"Protein-energy wasting and nutritional supplementation in patients with end-stage renal disease on hemodialysis","volume":"36","author":"Sabatino","year":"2017","journal-title":"Clin Nutr"},{"key":"2026101208471592500_bib37","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/nu9040399","article-title":"Nutritional status predicts 10-year mortality in patients with end-stage renal disease on hemodialysis","volume":"9","author":"Kang","year":"2017","journal-title":"Nutrients"},{"key":"2026101208471592500_bib38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000381798","article-title":"Geriatric nutritional risk index is a simple predictor of mortality in chronic hemodialysis patients","volume":"39","author":"Komatsu","year":"2015","journal-title":"Blood Purif"},{"key":"2026101208471592500_bib39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s40620-013-0033-0","article-title":"Geriatric nutritional risk index is a strong predictor of mortality in hemodialysis patients: data from the Riscavid cohort","volume":"27","author":"Panichi","year":"2014","journal-title":"J Nephrol"},{"key":"2026101208471592500_bib40","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/ki.2014.31","article-title":"Improving Global Outcomes Lipid Guideline Development Work Group Members. KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient","volume":"85","author":"Wanner","year":"2014","journal-title":"Kidney Int"},{"key":"2026101208471592500_bib41","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2215\/CJN.0000000683","article-title":"The association of fibrate use with kidney outcomes and mortality","volume":"20","author":"Takahashi","year":"2025","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026101208471592500_bib42","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1056\/NEJMoa2513032","article-title":"Fish-oil supplementation and cardiovascular events in patients receiving hemodialysis","volume":"394","author":"Lok","year":"2026","journal-title":"N Engl J Med"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag337\/71396137\/sfag337.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/10\/sfag337\/71396137\/sfag337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/10\/sfag337\/71396137\/sfag337.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:47:23Z","timestamp":1791809243000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag337\/8835807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag337","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,25]]},"article-number":"sfag337"}}